Swiftmerge Acquisition Corp is a blank check company. Swiftmerge Acquisition Corp is a blank check company.
$480 million Business Combination to Accelerate the Commercialization of an Innovative FDA-Approved Cardiovascular Disease Treatment HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held...
NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.0903342366757 | 11.07 | 11.22 | 11.07 | 65 | 11.07 | CS |
4 | 0.02 | 0.180831826401 | 11.06 | 11.22 | 11.06 | 122 | 11.06558063 | CS |
12 | 0.03 | 0.27149321267 | 11.05 | 11.22 | 11.02 | 5209 | 11.03479581 | CS |
26 | 0.25 | 2.30840258541 | 10.83 | 11.25 | 10.72 | 4722 | 10.96632809 | CS |
52 | 0.55 | 5.22317188984 | 10.53 | 12.2 | 10.45 | 9348 | 10.8430547 | CS |
156 | 0.58 | 5.52380952381 | 10.5 | 12.2 | 9.6701 | 35252 | 10.18057896 | CS |
260 | 0.58 | 5.52380952381 | 10.5 | 12.2 | 9.6701 | 35252 | 10.18057896 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約